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Key Clinical Message
This is a report of a patient with aspergillosis infection, which was thought to
be a tumoral lesion during its investigation. This is not a common disease in
Western countries, and this report should increase our awareness for differential
diagnosis of nasal masses. Early diagnosis is desired in order to increase the sur-
vival rates.
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Introduction
Among the existing forms of rhinosinusitis, fungal inva-
sive type is rare. However, its clinical relevance is due to
a high mortality rate – ranging from 50% to 90% [1, 2] –
and up to nearly 100% if intracranial mycotic dissemina-
tion is observed [3].
The acute invasive form is most found among immuno-
compromised patients because of their reduced capability
to mount an effective response against fungal infections
(marked neutropenia). It is characterized by an angioin-
vasive behavior, leading to necrosis of the affected tissues,
and rapid evolution – possibly affecting the orbit, palate,
and central nervous system (CNS), as the condition
develops. The chronic invasive form tends to affect patients
with subtler immune system abnormalities, as observed in
uncontrolled diabetes mellitus (especially with diabetic
ketoacidosis), prolonged corticoid therapy, and thyroid
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disorders [4]. Its presentation is an indolent, prolonged
course disease, with a better response to the treatment.
The granulomatous invasive form, whose causal agent is
usually the Aspergillus flavus, is mostly reported in Sudan,
India, Saudi Arabia, and Pakistan. The course of the dis-
ease is quite similar to the chronic invasive form, but it is
characterized by noncaseating granulomas, possibly with
giant cells and signs of vasculitis, with sparse hyphae,
histopathologically [5, 6].
Case Presentation
A 65-year-old woman was referred to the Department of
Otorhinolaryngology presenting a 5-month history of a
slowly progressive, oligosymptomatic orbital mass, caus-
ing left exophthalmia, left hemifacial pain, and ipsilateral
visual impairment, which eventually evolved to total
vision loss. The patient had an 8-year history of uncon-
trolled type 2 diabetes mellitus and a stage IIB adenocar-
cinoma of the cervix which had been successfully treated
with radiotherapy simultaneously with chemotherapy
(cisplatin 40 mg/m2, weekly), 3 years before. Other
comorbidities – adequately controlled with medication –
included systemic hypertension, dyslipidemia, and
hypothyroidism.
Physical examination presented a patient with left
exophthalmia, vision impairment, and complete restric-
tion of ocular motility. Anterior rhinoscopy and examina-
tion of the oral cavity were normal, as well of the neck
with no alterations or masses. Nasofibrolaryngoscopy
allowed perceiving a discrete medial bulging of the lateral
wall of the left nasal fossa, and a nasal septal deviation to
the left.
Computed tomography (CT) and magnetic resonance
imaging (MRI) of the orbital area were obtained. The CT
showed a lesion in the maxillary sinus with extension to
the orbital region, ethmoidal and sphenoid sinuses
(Fig. 1A and B). The MRI (Fig. 1C and D) showed
heterogenic expansive mass in the topography of the max-
illary sinus, nasal cavity, ethmoidal sinuses, and intraor-
bital region on the left, with signs of bone discontinuity
in the left orbit’s lateral and inferior walls. There was a
(1A) (1B)
(1C) (1D)
Figure 1. (A and B) Contrast-enhanced, high-resolution CT in axial and coronal plane images, respectively, showing a lesion with soft-tissue
density causing bone discontinuity of the maxilla, septal, sphenoid, ethmoidal, and pterygopalatine fossa (arrows). (C) T1-weighted postcontrast
MRI axial plane image showing a lesion with heterogeneous enhance affecting the left maxillary sinus, extending to the face. (D) T2-weighted
coronal plane image showing a heterogeneous mass in the region of the maxillary sinus, extending to the orbital region.
ª 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. 219
G. de Martin Truzzi et al. Chronic fungal rhinosinusitis: a review
deep extension through the inferior orbital fissure and
signs of invasion of the cavernous sinus on the left. There
were areas with restriction to diffusion semi-circumferen-
tially involving the ophthalmic nerve, and anterior devia-
tion of the extrinsic ocular muscles and its blood vessels.
Those findings were considered to be highly suggestive of
malignant neoplasm.
During admission, blood samples and cerebrospinal
fluid were collected to investigate infections, inflamma-
tion, neoplasia, or any other related disease (Tables 1 and
2). Also, the patient underwent to three consecutive biop-
sies. The first – right after the first presentation to the
service – approaches the left maxillary sinus region
through an endonasal endoscopic procedure. The analysis
of the sample was released in four weeks, showing an
intense lymphoplasmacytic proliferation that suggested a
chronic, nonspecific inflammatory process in contrast to
the probable diagnosis of a low-grade lymphoproliferative
lesion in the frozen section procedure. The paraffin fixa-
tion processing revealed nonspecific chronic fibrosing
inflammation, without evidence of neoplasia or granulo-
mas in the sample. No fungi were observed in the sample
(Fig. 2).
The second procedure, scheduled after obtaining the
results from the first biopsy, involved endoscopic endona-
sal orbital decompression of the affected side. At that
time, about 1 month after the patient’s first contact with
the institution, a granulomatous lesion was observed in
the nasal fossa. During decompression, tissue of necrotic
appearance was found, with drainage of a large volume of
secretion (Fig. 3).
Microscopic examination of the harvested material
turned out suggestive of fungal infection (namely asper-
gilloma), with no signs of vascular invasion (Fig. 4).
Meanwhile, approximately twenty days after the surgi-
cal decompression, the patient developed a contralateral
amaurosis. A new MRI scan revealed an expansion of the
lesion, which had extended into the anterior and middle
cranial fossae on the left and into the cavernous sinus.
Liposomal amphotericin B (IV, 5 mg/kg/per day) was ini-
tiated and kept for 20 days, but because there was no
clinical improvement, a third biopsy (through a Lynch
incision on the left) was then conducted, allowing the
collection of large samples showing an active chronic
necrotic inflammatory process, with dense accumulation
of hyphae. The volume of the obtained sample was
enough to definitively exclude neoplasm (Fig. 5). Cul-
tured material identified Aspergillus fumigatus. Voricona-
zole (IV, 6 mg/kg/dose, every 12 h) was then initiated for
treatment, under orientation of the hospital’s Infectious
Diseases Department. This triazole is also part of the ther-
apeutic arsenal against aspergillosis, and the shift from
amphotericin B was performed due to an overall
Table 1. Laboratory values at admission and during disease course.
August October November
Capsular antigen
Cryptococcus
neoformans
Negative
(latex
method
on blood
and liquor)
HbA1c (RV: 4–6) 8.8% 7.3%
CRP (RV < 0.3) 15.5 16.6
ESR (RV < 14) 120
FTA-ABS NR
Hepatitis C NR
HIV 1–2 NR
HBsAg NR
Anti-HBc +269.65 mUI/mL
Anti-HBc, total hepatitis B core antibody; CRP, C-reactive protein;
ESR, erythrocyte sedimentation rate; FTA-ABS, fluorescent treponemal
antibody absorption; HbA1c, glycated hemoglobin; HBsAg, hepatitis B
surface antigen; HIV 1–2, human immunodeficiency virus antigen 1
and 2; NR, nonreacting; RV, reference value.
Figure 2. Image reveals nonspecific acute and chronic inflammation,
without evidence of neoplasia or granulomas in the sample (H&E
stain, 60X magnification).
Table 2. Results from cerebrospinal fluid analysis.
IgG (RV < 3.4) 11.3
Neoplastic cells Negative
Fungi culture Negative
Mycobacteria Negative
Gram Negative
FTA-ABS Negative
ADA (RV < 9) 1.8
Proteins (RV < 42) 58
Glucose 66
WBC (RV < 3) 5
ADA, adenosine deaminase; FTA-ABS, fluorescent treponemal anti-
body absorption; RV, reference value; WBC, white blood cells.
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deterioration of the patients clinical status and a progres-
sive growth of the lesion with the latter antifungal drug.
During the entire hospitalization, the patient tended to
sustain high serum glucose levels, despite of intensive
monitoring and optimized insulin doses. Pathologies that
could potentially cause glycemic abnormalities were inves-
tigated, but no etiological factor was found, except for the
inflammatory process. The kidney function and liver
transaminases were normal during the entire hospitaliza-
tion, but hyponatremia without clinical repercussion was
perceived during the investigation and readily corrected.
No other radiological abnormalities were found, neither
indication of other fungal infections elsewhere. The
patient developed an acute ischemic stroke in the left car-
otid territory a few weeks after the initiation of voricona-
zole, presenting with a reduction in the level of
consciousness and right hemiplegia. The patient remained
under continuous intensive monitoring, having required
mechanical ventilation and the use of vasoactive drugs. A
encephalic CT scan showed a hypodensity in the territory
of the left carotid artery, with a midline shift that did not
require surgical decompression. The stroke eventually had
a fatal outcome a few days later.
Discussion
Aspergillus, Bipolaris, Curvularia, Alternaria, and Rhizomu-
cor, among others, are agents possibly found in fungal
rhinosinusitis [4–6]. There are several reports of fungal
rhinosinusitis and lesions associated with A. flavus in Iran
and in the rural population in India [7–9]. It is com-
monly seen in warm and dry climatic conditions, and it
is particularly common in young men from rural back-
ground [10]. The Aspergillus genre is becoming an
increasingly recognized pathogen in the nasal tract [11].
The A. flavus is most commonly associated with CNS
infection in both chronic invasive and granulomatous rhi-
nosinusitis, and frequently associated to vascular invasion,
whereas the A. fumigatus is commonly involved with
allergic fungal rhinosinusitis and aspergilloma [12].
Unlike acute invasive forms, the chronic invasive form
tends to present as an indolent and oligosymptomatic
infection, and symptoms may be present after weeks of
progression [6]. Initially, patients may report nonspecific
symptoms – similar to chronic rhinosinusitis – such as
headaches, nasal discharge, and facial pain. [7, 9]. The
most frequent complaints, as the disease progresses, are
visual impairment and orbital apex syndrome [6]. Com-
plications related to the orbital extension include presep-
tal cellulitis, orbital cellulitis, subperiosteal abscess, and
orbital abscess. The lesion grows contiguously, possibly
invading the CNS – which increases the mortality rate.
Another commonly described event that associates with a
worse prognosis of the patients is the cavernous sinus
thrombosis. Meningitis, encephalitis, and epidural, subdu-
ral and cerebral abscesses, as well as vascular emboli (or
even an arterial occlusion) and infarctions are some other
(3A) (3B)
Figure 3. (A) Endoscopic aspect of the left nasal fossa, presenting no secretion. (B) Following orbital decompression, a large volume of secretion
and necrotic tissue drained.
Figure 4. Aspergillosis detected under microscopic examination
(arrows), without vascular invasion indicating fungal invasion. No
neoplasia was found at the sample (PAS stain, 40X magnification).
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possible intracranial complications [13, 14]. The negative
outcome of the patient may have been caused by the
aforementioned intracranial vascular complication, lead-
ing to a severe ischemic insult. The extremely oligosymp-
tomatic development (which spammed over 10 months)
observed in this report was atypical, which retarded the
diagnosis.
Imaging examination shows a soft-tissue mass; bone
destruction and extension to the orbit, pterygopalatine
fossa, or intracranial regions are possible findings. CT
shows a hyperattenuating soft-tissue mass with calcifica-
tions in the nasal sinuses. On MRI, the lesion may have
iso- or hypointense T1 signal and is hypointense on T2-
weighted images. In some cases, it may be impossible to
distinguish this mass from a nasal sinus neoplasm, as
both may present bony wall destruction and extend
beyond the affected nasal sinus [15–17]. Other differential
diagnosis includes carcinoma, sarcoma, lymphoma, juve-
nile angiofibroma, inverted papilloma, meningioma, neu-
rofibroma, melanoma, and olfactory neuroblastoma
(esthesioneuroblastoma) [18]. The mentioned patient had
imaging which emulated a neoplastic disease – the first
diagnosis to be considered. The misleading image studies,
combined to biopsies that were negative for typical find-
ings of invasive fungal rhinosinusitis, lead to a retarded
diagnosis – and hence treatment – of this patient.
The conclusive diagnosis is possible by histopathologi-
cal examination with hematoxylin and eosin, periodic
acid–Schiff (PAS), Grocot, and methenamine silver stains.
The histopathology of the chronic invasive fungal rhinosi-
nusitis is characterized by a dense accumulation of
hyphae, infiltration of surrounding tissue [19], and vascu-
lar invasions (not found in noninvasive forms). Occasion-
ally, there is also lymphocytic infiltration, presence of
giant cells, granulomas, and necrotic tissue. A lesion may
begin as a mycetoma and develop into the invasive form,
especially in immunocompromised individuals [7, 9, 19–
21]. Some cases of allergic fungal rhinosinusitis may pre-
sent tissue invasion associated with granulomatosis. In
those cases, the most common associated pathogen is the
A. flavus [12]. In the presented case, the lack of vascular
invasion was a misleading factor, retarding the correct
diagnosis. Serum galactomannan was not used because it
was not available in our service by the time of this case
(5A)
(5B) (5C)
Figure 5. (A) Presence of numerous broad, septate hyphae of Aspergillus sp. (arrows) with characteristic branching at 45° angles (H&E stain-40X
magnification). (B) Aspergillus sp. hyphae (arrows) branching at 45° angles, highlighted by PAS stain (40X magnification). (C) At the image (10x
magnification), multiple Aspergillus sp. hyphae (arrow) are visible, highlighted by Grocott stain, also with hyphae branching at 45°.
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admission. It is also known the high rates of false positive
and that is most indicated in cases of hematological
malignancies [22]. Characteristically, large, nonchambered
hyphae with right-angle branching are suggestive of
Mucor, whilst Aspergillus shows smaller, chambered
hyphae that branch at 45° angles [23], as presented by
the patient in this report [24].
The optimal treatment consists of broad surgical
debridement of involved tissues – provided it is clinically
and technically possible – along with prolonged use of
systemic antifungal medication (e.g., intravenous liposo-
mal amphotericin B as a first choice, or voriconazole)
and strict control of underlying medical disorders.
Patients with neurological invasion have high mortality
rates, requiring an aggressive treatment every time it is
possible, similarly to the acute fungal invasive form. [20,
21]. Patients should keep regular follow-ups after the
treatment, as the pathology is frequently recurrent.
Conclusion
Chronic invasive fungal rhinosinusitis is a condition with
complications of great potential morbidity and mortality.
The clinical presentation may be poorly defined, and
imaging characteristics are sometimes indistinguishable
from nasal sinus neoplasms. The biopsy is the gold stan-
dard method to define the diagnosis, and early treatment
allows a better prognosis.
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